ArticleThe Biochemical journal2000
Shedding of somatic angiotensin-converting enzyme (ACE) is inefficient compared with testis ACE despite cleavage at identical stalk sites.
Article in The Biochemical journal, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure.Pharmacological reviews · 2019Review
- Lysozyme and bilirubin bind to ACE and regulate its conformation and shedding.Scientific reports · 2016Article
- Tissue Specificity of Human Angiotensin I-Converting Enzyme.PloS one · 2015Article
- Absence of cell surface expression of human ACE leads to perinatal death.Human molecular genetics · 2014Article
- Rediscovering ACE: novel insights into the many roles of the angiotensin-converting enzyme.Journal of molecular medicine (Berlin, Germany) · 2013Review
- A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.Pharmacological reviews · 2013Review
- Article
- Article
- N-domain isoform of Angiotensin I converting enzyme as a marker of hypertension: populational study.International journal of hypertension · 2012Article
- An angiotensin I-converting enzyme mutation (Y465D) causes a dramatic increase in blood ACE via accelerated ACE shedding.PloS one · 2011Article
- Angiotensin I-converting enzyme mutation (Trp1197Stop) causes a dramatic increase in blood ACE.PloS one · 2009Article
- Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia.American journal of physiology. Lung cellular and molecular physiology · 2009Article
- The influence of mouse Ped gene expression on postnatal development.The Journal of physiology · 2006Article
- The angiotensin-converting enzyme (ACE) gene family of Anopheles gambiae.BMC genomics · 2005Article
- Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor.The Journal of biological chemistry · 2005Article
- The N domain of somatic angiotensin-converting enzyme negatively regulates ectodomain shedding and catalytic activity.The Biochemical journal · 2005Article
- Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.The Biochemical journal · 2004Article
- Ace revisited: a new target for structure-based drug design.Nature reviews. Drug discovery · 2003Review
- Epitope-specific antibody-induced cleavage of angiotensin-converting enzyme from the cell surface.The Biochemical journal · 2002Article
- Roles of the juxtamembrane and extracellular domains of angiotensin-converting enzyme in ectodomain shedding.The Biochemical journal · 2001Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The somatic and testis isoforms of angiotensin-converting enzyme (ACE) are both C-terminally anchored ectoproteins that are shed by an unidentified secretase. Although testis and somatic ACE both share the same stalk and membrane domains the latter was reported to be shed inefficiently compared with testis ACE, and this was ascribed to cleavage at an alternative site [Beldent, Michaud, Bonnefoy, Chauvet and Corvol (1995) J. Biol. Chem. 270, 28962-28969]. These differences constitute a useful model system of the regulation and substrate preferences of the ACE secretase, and hence we investigated this further. In transfected Chinese hamster ovary cells, human somatic ACE (hsACE) was indeed shed less efficiently than human testis ACE, and shedding of somatic ACE responded poorly to phorbol ester activation. However, using several analytical techniques, we found no evidence that the somatic ACE cleavage site differed from that characterized in testis ACE. First, anti-peptide antibodies raised to specific sequences on either side of the reported cleavage site (Arg(1137)/Leu(1138)) clearly recognized soluble porcine somatic ACE, indicating that cleavage was C-terminal to Arg(1137). Second, a competitive ELISA gave superimposable curves for porcine plasma ACE, secretase-cleaved porcine somatic ACE (eACE), and trypsin-cleaved ACE, suggesting similar C-terminal sequences. Third, mass-spectral analyses of digests of released soluble hsACE or of eACE enabled precise assignments of the C-termini, in each case to Arg(1203). These data indicated that soluble human and porcine somatic ACE, whether generated in vivo or in vitro, have C-termini consistent with cleavage at a single site, the Arg(1203)/Ser(1204) bond, identical with the Arg(627)/Ser(628) site in testis ACE. In conclusion, the inefficient release of somatic ACE is not due to cleavage at an alternative stalk site, but instead supports the hypothesis that the testis ACE ectodomain contains a motif that activates shedding, which is occluded by the additional domain found in somatic ACE.
Indexed as
Identifiers
10769174PMC1221007What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.